Premium
NEW INSIGHTS INTO THE TREATMENT OF HYPERTENSION
Author(s) -
Tomlinson Brian
Publication year - 1997
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.1997.tb02733.x
Subject(s) - chemistry , pharmacology , medicine , computational biology , biology
SUMMARY 1. The choice of initial pharmacological therapy is one area where the different hypertension management guidelines vary in recommending either the use of diuretics and beta‐blockers as preferred drugs or choosing from any of the five major classes of antihypertensives. 2. Improvement in cardiovascular morbidity and mortality may have been shown most conclusively with diuretics and beta‐blockers, but the effects on coronary events with these drugs were less than predicted and the other agents have a number of theoretica. advantages. 3. Recent worries regarding the possible adverse effects of calcium antagonists have led to a reappraisal of the risks and benefits of these drugs and antihypertensives i. general. 4. Many patients, particularly the elderly, have other conditions that influence the choice of first‐line therapy and ethnic variations in the effects of hypertension or the efficacy or side effects of drugs should also be taken int. account. 5. There is considerable heterogeneity within the major categories of antihypertensive drugs, so it is important to distinguish the different subgroups, dosages and formulations that may b. used.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom